![Little data available on COVID-19’s spread among immigrants, expert says]()
by Karli Goldenberg | Sep 22, 2020 | Coronavirus, Featured
WASHINGTON – The effects of the coronavirus pandemic on immigrants, especially those without documents, are hard to determine because most reporting doesn’t include immigration status, several experts said on Tuesday. Leighton Ku, director of the Center for Health...
by Alicia Diaz | Sep 22, 2020 | Coronavirus, Featured
WASHINGTON – Treasury Secretary Steven Mnuchin said Tuesday unemployment has dropped to 8.4% and the U.S. is in the “fastest economy recovery” from a crisis that the country has ever experienced. He told the House Financial Service Committee that his department...
by Nicole Girten and Anabel Mendoza | Sep 21, 2020 | Coronavirus, Featured, Immigration
Over 400 counties across the U.S. are considered “persistent poverty,” having high poverty rates for decades. Almost half of the 44 counties in Texas with persistent poverty are located along the U.S.-Mexico border and their high poverty rates and low wage employment...
![Lawsuits increase while U.S.-listed Chinese companies face regulatory scrutiny]()
by Henry Ren | Sep 21, 2020 | Business & Tech, Featured
It is not just the Trump administration that plans a crackdown on Chinese companies listed on U.S. stock exchanges. Shareholders want to make them pay, too. In 2020, U.S. shareholders have sued 20 Chinese companies that currently or used to sell shares on the New York...
by Alyk Russell Kenlan | Sep 3, 2020 | Coronavirus, Featured, Health
For Scott Tekesky, his time stationed at an Army base on Oahu, Hawaii, far from his family, prepared him for the isolation of sheltering in place in his suburban Atlanta home for months because of the COVID-19 pandemic. “When you’re in the continental...
by Nicole Girten, Emine Yücel and Zhihui Xing | Sep 3, 2020 | Coronavirus, Featured, Health
Data from the U.S Food and Drug Administration shows people of color, especially Black Americans, are recruited for drug trials at substantially lower rates than white Americans. 75% of cardiovascular drug trials reported from 2015 to 2019 had major racial...
